He is also the chairman of the China Entrepreneur Club, a non-profit organization that promotes the development of Chinese entrepreneurs. Jiang Rensheng is one of the wealthiest people in China and is ranked as the 18th richest person in the world.
Jiang Rensheng is a Chinese entrepreneur with an estimated net worth of $17.1 billion. He is the founder and chairman of Chongqing Zhifei Biological Products, one of the world's largest vaccine producers, and the chairman of the China Entrepreneur Club. He is one of the wealthiest people in China and is ranked as the 18th richest person in the world.
Jiang Rensheng is a member of Richest Billionaires
Age, Biography and Wiki
Birth Place |
China |
Net Worth: |
$17.1 Billion |
💰 Net worth: $12.2 Billion (2024)
Jiang Rensheng, widely recognized as one of the wealthiest individuals in China, is anticipated to have a net worth of an astounding $12.2 billion by the year 2024. His remarkable financial success can be attributed to his tireless efforts in building a business empire. Jiang Rensheng has consistently demonstrated exceptional entrepreneurial skills, allowing him to amass incredible wealth. His transformative leadership and strategic decision-making have contributed immensely to his ascent as one of China's richest billionaires.
Some Jiang Rensheng images
Jiang Rensheng Net Worth: Jiang Rensheng is a Chinese entrepreneur who has a net worth of $17.1 billion. Born in October, 1953, Jiang Rensheng made his fortune as the founder and chairman of Chongqing Zhifei Biological Products, one of the world's largest vaccines producer. A graduate of Guilin Medical University, he worked as a health official in Guanxi Province before he founded his company in 2001.
Through the years, his company has grown into a massive vaccines maker, which in 2012 signed a distribution deal for a vaccine for cervical cancer with the American pharmaceutical company Merck & Co. In 2012, Ransheng's fortune has enlarged from $1.1 billion thanks to over 50% rise of the company's shares on the Shenzhen stock exchange market. Last year, the company's sale climbed for 30% to $70 million.